Results from first global survey of neuroendocrine tumor (NET) patients reveal profound impact of this rare cancer on quality of life

Results from first global survey of neuroendocrine tumor (NET) patients reveal profound impact of this rare cancer on quality of life

Neurology News & Neuroscience News from Medical News Today

Novartis and the International Neuroendocrine Cancer Alliance (INCA) announced the quality-of-life results from the first global survey of patients with neuroendocrine tumors (NETs), a rare type of...

Original Article: http://www.medicalnewstoday.com/releases/284970.php

Julio Pereira

http://weneuro.com/ 

http://www.linkedin.com/in/juliommais

http://lattes.cnpq.br/7687651239699170

Consultório (11) 3141-9550 / (11) 3141-9553